SLC16A13
Monocarboxylate transporter 13
Also known as: MCT13, MOT13_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7RTY0
- Gene
- SLC16A13
- Ensembl
- ENSG00000174327
- Chromosome
- 17
- Canonical length
- 426 aa
- Protein class
- Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters
- Subcellular location
- Golgi apparatus,Cytosol
OverviewNCBI Gene
Predicted to enable monocarboxylic acid transmembrane transporter activity. Predicted to be involved in monocarboxylic acid transport and transmembrane transport. Located in Golgi apparatus and cytosol. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
426 residues, UniProt reviewed canonical sequence.
>Q7RTY0|SLC16A13
1 MARRTEPPDG GWGWVVVLSA FFQSALVFGV LRSFGVFFVE FVAAFEEQAA RVSWIASIGI
61 AVQQFGSPVG SALSTKFGPR PVVMTGGILA ALGMLLASFA TSLTHLYLSI GLLSGSGWAL
121 TFAPTLACLS CYFSRRRSLA TGLALTGVGL SSFTFAPFFQ WLLSHYAWRG SLLLVSALSL
181 HLVACGALLR PPSLAEDPAV GGPRAQLTSL LHHGPFLRYT VALTLINTGY FIPYLHLVAH
241 LQDLDWDPLP AAFLLSVVAI SDLVGRVVSG WLGDAVPGPV TRLLMLWTTL TGVSLALFPV
301 AQAPTALVAL AVAYGFTSGA LAPLAFSVLP ELIGTRRIYC GLGLLQMIES IGGLLGPPLS
361 GYLRDVTGNY TASFVVAGAF LLSGSGILLT LPHFFCFSTT TSGPQDLVTE ALDTKVPLPK
421 EGLEEDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC16A13 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 12
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- liver: 34 nTPM
- duodenum: 8.7 nTPM
- kidney: 6.4 nTPM
- small intestine: 5.2 nTPM
- skin: 5 nTPM
- esophagus: 4.9 nTPM
Single-cell type
- paneth cells: 31 nCPM
- tuft cells: 23 nCPM
- proximal tubule cells: 19 nCPM
- enterocytes: 15 nCPM
- conjunctival goblet cells: 15 nCPM
- müller glia: 14 nCPM
Immune cell
- naive B-cell: 2.5 nTPM
- memory CD8 T-cell: 1.5 nTPM
- gdT-cell: 1.2 nTPM
- NK-cell: 1.2 nTPM
- T-reg: 1.2 nTPM
- memory B-cell: 1.1 nTPM
Brain region
- cerebellum: 4.7 nTPM
- medulla oblongata: 3.4 nTPM
- midbrain: 3.3 nTPM
- thalamus: 3.2 nTPM
- amygdala: 3.1 nTPM
- cerebral cortex: 3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SLC16A13.
Disease | AllUniProt
Conditions SLC16A13 is implicated in, by any mechanism.
- Type 2 diabetes mellitus (T2D) MIM:125853
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 60 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.71
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.18
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC16A13 as an antibody target. Whether an autoantibody or antibody against SLC16A13 could matter depends on whether native SLC16A13 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC16A13 is annotated at the cell surface, where native SLC16A13 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC16A13 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...